戻る Agenda
Enabling and Constraining Factors in Commercial ATMP Development: Learnings from the Escher-ATMP study
Session Chair(s)
Renske M.T. Ten Ham, PharmD
Utrecht University, Netherlands
Advanced Therapy Medicinal Products(ATMP), gene, cell and tissue-based products, are highly innovative. Despite efforts, few have reached the market. Escher-Lygature study is the first to research challenges in their development.